Search

Copyright of Canadian Journal of Hospital Pharmacy / Journal Canadien de la Pharmacie Hospitalière is the property of Canadian Society of Hospital Pharmacists and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

The main objective is to evaluate RFID tags detection rates using various exploratory scenarios in order to identify optimal conditions of use. The secondary objective is to evaluate RFID tags detection rates based on a real-life scenario involving a cardiorespiratory resuscitation drug tray used within our institution in order to identify optimal conditions of use.

Résumé: La diffusion de données et d'indicateurs à l'équipe de la pharmacie comporte plusieurs bénéfices théoriques, mais ceux-ci sont peu diffusés et doivent être adaptés aux besoins de l'équipe. Méthodes. Étude descriptive transversale. L'objectif est de décrire l'utilisation actuelle et projetée d'indicateurs de gestion en pharmacie hospitalière au sein d'un centre hospitalier universitaire. La situation actuelle de la diffusion et de l'utilisation de données et d'indicateurs a été décrite. Des indicateurs et données d'intérêt ont été identifiés par revue de la littérature et en consultant les chefs d'équipe des secteurs visés. Un sondage a été envoyé à l'équipe. Chaque répondant devait coter les indicateurs d'intérêt de leur(s) secteur(s) de pratique selon un score de priorité d'affichage, permettant de calculer un score pondéré pour chaque donnée et indicateur. Résultats. Cinquante-sept réponses ont été obtenues (taux de participation de 63,3 % ; 57/90 personnes disponibles, soit 31 pharmaciens, 23 préparateurs, 2 membres non identifiés et 1 membre autre). Des 93 données et indicateurs proposés, le score pondéré de priorité d'affichage varie de 1,44 à 4,05 par item (moyenne de 2,69 ± 0,52). En utilisant arbitrairement un seuil de 2,5 ou moins, 37 de ces données et indicateurs ont été priorisés. Conclusion. Cette étude décrit une démarche structurée pour évaluer et sélectionner des données et indicateurs en vue de les diffuser aux membres d'un département de pharmacie via un tableau de bord. Un total de 93 données et indicateurs ont été identifiés par les membres de l'équipe afin de soutenir les pratiques en pharmacie hospitalière. Several theoretical benefits of disseminating data and indicators to the pharmacy team exist, but they are not usually distributed, and they must be adapted to the pharmacy team's needs. Methods: This is a descriptive cross-sectional study. The objective is to describe the current and projected use of hospital pharmacy management indicators within a university hospital center. The current state of dissemination and use of data and indicators was described. Indicators and data of interest were identified from a literature review and by consulting targeted sectors' team leaders. A survey was sent to the team where each respondent rated the indicators of interest for their area(s) of practice according to a display priority score, allowing for a weighted score to be calculated for each data and indicator. Results: Fifty-seven responses were obtained (participation rate of 63.3%; 57/90 people available, i.e., 31 pharmacists, 23 preparers, 2 unidentified members and 1 other member). Of the 93 data and indicators available, the weighted display priority score ranges from 1.44 to 4.05 per item (average of 2.69 ± 0.52). Using an arbitrary threshold of 2.5 or less, 37 of these data and indicators were prioritized. Conclusion: This study describes a structured process for evaluating and selecting data and indicators with the objective to share them to members of a pharmacy department via a dashboard. A total of 93 data and indicators were identified by team members to support hospital pharmacy practices. [ABSTRACT FROM AUTHOR]

Résumé: La pandémie du coronavirus SRAS-CoV-2 (Covid-19) a nécessité la mise en place de mesures sanitaires sérieuses. L'objectif principal est de décrire l'expérience vécue par un département de pharmacie en comparant le recours au travail à distance et au télétravail avant et depuis la pandémie. Méthode. Cette étude descriptive et rétrospective se déroule dans un centre hospitalier de 500 lits. Les éléments suivants ont été recensés : identification des politiques, des procédures et des tâches admissibles au travail à distance ou au télétravail en ce qui concerne la gestion pharmaceutique, les soins, les services, la recherche et l'enseignement. L'état de situation prépandémie a été établi. Résultats. Depuis la pandémie, des changements de pratique ont été apportés : la relocalisation de postes de travail, l'activation d'un accès à distance pour tous, l'identification des opportunités de télétravail, la mise en place d'un environnement de travail fonctionnel à domicile et la réévaluation des outils de communication. Conclusion. Cette étude met en évidence l'expérience d'un centre hospitalier universitaire canadien durant la pandémie. The coronavirus SARS-CoV-2 (COVID-19) pandemic caused a worldwide crisis. Serious sanitary measures were recommended by public health organizations to limit the risks of contamination and distancing measures have been implemented. The main objective is to describe the experience of a center with distancing measures and telework and to compare it before and during the COVID-19 pandemic. Methods. This descriptive and retrospective study takes place at a 500-bed hospital. This study consisted of a review of the pharmacy department's politics and procedures and of the pharmaceutical tasks that were eligible to telework (management, pharmaceutical care, services, research and teaching). The situation before the pandemic was established. Results. During the COVID-19 pandemic, changes were reported including: distancing measures with relocation of workstations, remote access activations, identification of telework opportunities, development of a functional telework environment and revaluation of the communication tools. Conclusion. There is limited data available on physical distancing and telework in pharmacy. This descriptive study highlights the experience of a Canadian hospital during the COVID-19 pandemic. [ABSTRACT FROM AUTHOR]

Résumé: Le circuit du médicament est un élément central de l'organisation d'un établissement de santé. L'objectif principal est de décrire le circuit du médicament dans deux centres hospitaliers universitaires (un français et un canadien), identifier et discuter les similitudes et différences. Méthode : Il s'agit d'une étude descriptive transversale de type qualitative menée d'août à septembre 2019. Deux établissements pédiatriques de santé ont été identifiés, soit l'hôpital universitaire Necker-Enfants Malades (HUNEM) à Paris, France et le centre hospitalier universitaire Sainte-Justine (CHUSJ) à Montréal, Québec, Canada. À partir d'une séance de réflexion collective, nous avons développé une grille d'analyse incluant 22 items qui caractérisent le profil de chaque établissement, 23 liés au profil de la pharmacie à usage intérieur et 20 autres décrivant les étapes du circuit du médicament. Les membres de l'équipe de recherche de chaque établissement de santé ont complété le contenu de la grille, revu et commenté les réponses de l'autre établissement. Nous avons indiqué pour l'ensemble des items les similitudes ou différences entre les deux établissements. Résultats : Parmi les différences, on note un nombre de pharmaciens (36,4 vs 15 en équivalent temps plein) et de préparateurs en pharmacie (50 vs 23,3 en équivalent temps plein) deux fois plus élevé, une dispensation nominative et la préparation d'un plus grand nombre de doses dans un format prêt à l'emploi pour le personnel infirmier et un droit de prescription des pharmaciens au CHUSJ. À HUNEM, on observe un périmètre d'activité plus important, des dépenses plus importantes (95 vs 17 millions d'euros) et une robotisation davantage déployée. L'étude met en évidence 11 similitudes et 9 différences sur les 20 étapes du circuit du médicament. Conclusion : Il s'agit d'une étude décrivant le circuit du médicament dans deux centres hospitaliers universitaires : un canadien et un français. Il existe autant de similitudes que de différences entre les deux centres en ce qui concerne les services et soins pharmaceutiques. Il est difficile de comparer la pratique pharmaceutique au sein de deux établissements de santé provenant de deux pays, compte tenu du grand nombre d'éléments et de termes qui diffèrent. Ce type de comparaison nous paraît utile pour favoriser une meilleure compréhension des pratiques entre la France et le Canada. Elle peut également contribuer à favoriser l'évolution des services et soins dans chaque pays en profitant des données recueillies. D'autres échanges sont toutefois nécessaires afin d'évaluer les retombées des approches mises en place dans chaque pays. The drug circuit is central to the organization of a health facility. Objective : The main objective is to describe the drug circuit in a French and Canadian university hospital center, identify and discuss similarities and differences. Method : This is a qualitative cross-sectional descriptive study conducted from August to September 2019. Two pediatric health establishments have been identified, namely Necker-Enfants Malades University Hospital (HUNEM) in Paris, France and the University Hospital Center Sainte-Justine (CHUSJ) in Montreal, Quebec, Canada. From a brainstorming session, we developed an analysis grid including 22 items that characterize the profile of each institution, 23 items related to the profile of the indoor pharmacy and 20 others items describing the steps of the drug circuit. Research team members from each health facility completed the grid content, reviewed and commented on the other institution's responses. For all items, we indicated the similarities or differences between the two hospitals. Results : Among the differences were a number of pharmacists (36.4 vs 15) and pharmacy technicians (50 vs 23.3) twice as high, a nominal dispensing and the preparation of the largest number of doses in a ready-to-use format for nurses and a prescription right for pharmacists at the CHUSJ. In HUNEM, there was a greater scope of activity, larger expenses (95 vs 17 million euros) and more extensive robotization. The study highlighted 11 similarities and 9 differences over the 20 steps of the drug circuit. Discussion-conclusion : This is a study describing the drug circuit in two university hospitals: a Canadian and a French. There are as many similarities as differences between the two centers in terms of pharmaceutical services and care. It is difficult to compare pharmaceutical practice in two healthcare facilities from two countries, given the large number of elements and terms that differ. This type of comparison seems useful to us for promoting a better understanding of the practices between France and Canada. It can also help foster the development of services and care in each country by taking advantage of the data collected. However, other exchanges are necessary in order to assess the impact of the approaches implemented in each country. [ABSTRACT FROM AUTHOR]

The article discusses the study on the evaluation of nursing staff's feeling regarding the effect of automated dispensing cabinets (ADCs) safe delivery of healthcare ergonomics. Topics discussed include the use of questionnaire for the evaluation, response of the nurses regarding the use of ADCs, non satisfaction of additional delays in administration and preparation of medication dose.

Competing Interests: Competing interests: None declared.

In this chapter we describe the current Quebec NTBC Study protocol. Quebec's unique characteristics have influenced the development of the protocol, including a high prevalence of hepatorenal tyrosinemia (HT1), universal newborn screening for HT1, availability of treatment with nitisinone (NTBC) and special diet, a large territory, where HT1 treatment is coordinated by a small number of centers. Screened newborns are seen within 3 weeks of birth. Patients with liver dysfunction (prolonged prothrombin time and/or international normalized ratio (INR) provide sensitive, rapidly available indicators) are treated by NTBC and special diet. The specific diagnosis is confirmed by diagnostic testing for succinylacetone (SA) in plasma and urine samples obtained before treatment. After an initial period of frequent surveillance, stable patients are followed every 3 months by assay of plasma amino acids and NTBC and plasma and urine SA. Abdominal ultrasound is done every 6 months. Patients have an annual visit to the coordinating center that includes multidisciplinary evaluations in metabolic genetics, hepatology, imaging (for abdominal ultrasound and magnetic resonance imaging) and other specialties as necessary. If hepatocellular carcinoma is suspected by imaging and/or because of progressive elevation of alphafetoprotein, liver transplantation is discussed. To date, no patient in whom treatment was started before 1 month of age has developed hepatocellular carcinoma, after surveillance for up to 20 years in some. This patient group is the largest in the world that has been treated rapidly following newborn screening. The protocol continues to evolve to adapt to the challenges of long term surveillance.

Context: Few data are available on the use and consequences of decentralized automated dispensing cabinets (ADCs) in institutional settings., Method: This descriptive study examined compliance with published guidelines on the implementation of decentralized ADCs. The primary objective was to evaluate overall compliance, as well as compliance with specific steps in the medication cycle. The study was carried out at the Centre hospitalier universitaire (CHU) Sainte-Justine, a 500-bed mother-and-child hospital. The 2008 guidelines of the Institute for Safe Medication Practices (US) concerning the safe use of decentralized ADCs and the associated self-assessment tool (2009) were used to evaluate compliance at 30 days and at 120 days after implementation., Results: From November 2009 to April 2010, 7 decentralized ADCs were brought into service at the CHU Sainte-Justine. Overall compliance with published guidelines increased from 66% to 74% between January and April 2010. For each process related to the safe use of the ADCs, the criteria were briefly described, along with the non-compliance components related to technological or organizational aspects of implementation. For each component for which practice was noncompliant with guidelines, the actions required to modify the equipment (i.e., technological aspects) were determined and conveyed to the manufacturer; similarly, modes of use requiring modification (i.e., organizational aspects) were determined and conveyed to the institution., Conclusion: This study has described the compliance of practices at the CHU Sainte-Justine with published guidelines of the Institute for Safe Medication Practices. The use of published guidelines can help to guide both the technological and organizational aspects of implementing decentralized ADCs. [Publisher's translation].